Immunotherapy of malignant diseases--developments and prospects

Wiener medizinische Wochenschrift
Patricia PaukovitsHans Loibner

Abstract

Conventional strategies in cancer management, such as surgery, chemotherapy or radiation therapy are effective treatments for most tumors, but often fail in achieving complete remission. The reason for this failure is, that single tumor cells have already spread to various organs by the time the tumor is diagnosed and lead, often years later, to the development of metastases. Therefore it is insufficient to treat the tumor solely at its point of origin; tumor dissemination should be prevented too. Tumor immunotherapy is one of the treatment options that target tumor propagation. In cancer immunotherapy, the immune system of the patient is influenced such, that the tumor is recognized and attacked by the body's defences. Since these therapies specifically aim at tumor cells, they cause fewer adverse events and improve the quality of life of patients. This review outlines previous developments in cancer immunotherapies with a focus on active immunotherapies and vaccination strategies.

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Advances in Experimental Medicine and Biology
Qijin XuJohn S Yu
Journal of Zhejiang University. Science. B
Xinguo Jiang
Nihon rinsho. Japanese journal of clinical medicine
Yutaka KawakamiShigeki Ohta
Gan to kagaku ryoho. Cancer & chemotherapy
K Toyoshima
Seminars in Oncology
Stephen G SwisherDavid P Carbone
© 2022 Meta ULC. All rights reserved